BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16531269)

  • 1. The value of autofluorescence as a diagnostic feature of acute promyelocytic leukemia.
    Hayden PJ; O'Connell NM; O'Brien DA; O'Rourke P; Lawlor E; Browne PV
    Haematologica; 2006 Mar; 91(3):417-8. PubMed ID: 16531269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain infarction and blasts with bilobed nuclei in a patient with monocytic acute myeloid leukemia mimicking acute promyelocytic leukemia.
    Elghazaly AA; Ibrahim MH; AlGwaiz LA
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):116-7. PubMed ID: 26802620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR antigen-positive acute promyelocytic leukemia.
    Mendoza AS; Qing X; Dungo M; Lasky J; Panosyan E; Cai J
    Exp Mol Pathol; 2016 Oct; 101(2):197-200. PubMed ID: 27544027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsed Acute Promyelocytic Leukemia Lacks "Classic" Leukemic Promyelocyte Morphology and Can Create Diagnostic Challenges.
    Dayton VJ; McKenna RW; Yohe SL; Dolan MM; Courville E; Alvarez H; Linden MA
    Am J Clin Pathol; 2017 Jan; 147(1):69-76. PubMed ID: 28108472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.
    Gupta M; Jafari K; Rajab A; Wei C; Mazur J; Tierens A; Hyjek E; Musani R; Porwit A
    Cytometry B Clin Cytom; 2021 Jul; 100(4):409-420. PubMed ID: 33301193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical features in a patient with acute promyelocytic leukaemia: a potential diagnostic pitfall.
    Mohamed M; Dun K; Grabek J
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24014332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
    Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig WD; Gratama J; Orfao A;
    Cytometry B Clin Cytom; 2006 Jan; 70(1):1-9. PubMed ID: 16278833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PML immunofluorescence, flow cytometric immunophenotypic analysis, and reverse transcriptase polymerase chain reaction for PML/RARa for rapid diagnosis of acute promyelocytic leukemia.
    Varma N; Agarwal C; Varma S
    Cancer; 2011 Jan; 117(2):435; author reply 435-6. PubMed ID: 20845483
    [No Abstract]   [Full Text] [Related]  

  • 11. The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells.
    Grimwade D; Outram SV; Flora R; Ings SJ; Pizzey AR; Morilla R; Craddock CF; Linch DC; Solomon E
    Cancer Res; 2002 Aug; 62(16):4730-5. PubMed ID: 12183432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry analysis of acute promyelocytic leukemia: the power of 'surface hematology'.
    Di Noto R; Mirabelli P; Del Vecchio L
    Leukemia; 2007 Jan; 21(1):4-8. PubMed ID: 17167527
    [No Abstract]   [Full Text] [Related]  

  • 13. Microgranular acute promyelocytic leukemia: a proposed role for a greater deformability of the leukemic cell.
    Cantin G; Bernier V; Jacob S; Lyonnais J
    Nouv Rev Fr Hematol (1978); 1989; 31(1):23-6. PubMed ID: 2915920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocalyxin is expressed in normal and leukemic monocytes.
    Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
    Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD2+ acute promyelocytic leukemia is associated with leukocytosis, variant morphology and poorer prognosis.
    Kaito K; Katayama T; Masuoka H; Nishiwaki K; Sano K; Sekiguchi N; Hagino T; Kobayashi M
    Clin Lab Haematol; 2005 Oct; 27(5):307-11. PubMed ID: 16178910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia.
    Heiblig M; Paubelle E; Plesa A; Geay MO; Manzoni D; Gazzo S; Tigaud I; Callet-Bauchu E; Huet S; Salles G; Thomas X; Hayette S; Sujobert P
    Blood; 2017 Jan; 129(1):128-131. PubMed ID: 27827828
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of CD11a and CD18 in flow cytometric immunophenotypic analysis for diagnosis of acute promyelocytic leukemia.
    Zhou Y; Jorgensen JL; Wang SA; Ravandi F; Cortes J; Kantarjian HM; Medeiros LJ; Konoplev S
    Am J Clin Pathol; 2012 Nov; 138(5):744-50. PubMed ID: 23086776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India.
    Gujral S; Badrinath Y; Kumar A; Subramanian PG; Raje G; Jain H; Pais A; Amre Kadam PS; Banavali SD; Arora B; Kumar P; Hari Menon VG; Kurkure PA; Parikh PM; Mahadik S; Chogule AB; Shinde SC; Nair CN
    Cytometry B Clin Cytom; 2009 May; 76(3):199-205. PubMed ID: 18803279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T; Babusíková O
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.